This session will focus on the scientific and clinical progress of novel platform technologies. Panelists will share clinical data on current vaccine targets in development and discuss how their platform can be deployed against emerging or unknown pathogens with pandemic or epidemic potential. The group will discuss how to implement policies that invest in these technologies that allow for the dual-use development of vaccines with commercial, emerging infection and outbreak purposes.

Session ID: 545493